Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05850585Not yet recruiting
Randomised, double-blind trial of Fecal Microbiota Transplantation Capsule in schizophrenia (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Positive and Negative Syndrome Scale at 8 weeks. Planned start Jul 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05850585.